Cargando…

Cytokine release syndrome

During the last decade the field of cancer immunotherapy has witnessed impressive progress. Highly effective immunotherapies such as immune checkpoint inhibition, and T-cell engaging therapies like bispecific T-cell engaging (BiTE) single-chain antibody constructs and chimeric antigen receptor (CAR)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimabukuro-Vornhagen, Alexander, Gödel, Philipp, Subklewe, Marion, Stemmler, Hans Joachim, Schlößer, Hans Anton, Schlaak, Max, Kochanek, Matthias, Böll, Boris, von Bergwelt-Baildon, Michael S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003181/ https://www.ncbi.nlm.nih.gov/pubmed/29907163 http://dx.doi.org/10.1186/s40425-018-0343-9

Ejemplares similares

Ten things the hematologist wants you to know about CAR-T cells
por: Böll, Boris, et al.
Publicado: (2020)

CCC meets ICU: Redefining the role of critical care of cancer patients
por: von Bergwelt-Baildon, Michael, et al.
Publicado: (2010)

Improvement of platelet dysfunction in chronic myelogenous leukemia following treatment with imatinib: a case report
por: Shimabukuro-Vornhagen, Alexander, et al.
Publicado: (2011)

The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells
por: Shimabukuro-Vornhagen, Alexander, et al.
Publicado: (2012)

In the Eye of the Storm: Immune-mediated Toxicities Associated With CAR-T Cell Therapy
por: Garcia Borrega, Jorge, et al.
Publicado: (2019)

Acquired Long QT Syndrome and Torsade de Pointes Associated with HIV Infection
por: Shimabukuro-Vornhagen, Alexander, et al.
Publicado: (2010)

Prognostic accuracy of SOFA, qSOFA and SIRS criteria in hematological cancer patients: a retrospective multicenter study
por: Probst, Lucie, et al.
Publicado: (2019)

Clinicopathologic Findings in Fatal Neurotoxicity After Adoptive Immunotherapy With CD19-Directed CAR T-Cells
por: Karschnia, Philipp, et al.
Publicado: (2021)

CD40-activated B cells induce anti-tumor immunity in vivo
por: Wennhold, Kerstin, et al.
Publicado: (2016)

Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes—results of a retrospective analysis from a German university hospital
por: Garcia Borrega, Jorge, et al.
Publicado: (2021)

Pretransplant Comorbidities Maintain Their Impact on Allogeneic Stem Cell Transplantation Outcome 5 Years Posttransplant: A Retrospective Study in a Single German Institution
por: Chemnitz, Jens M., et al.
Publicado: (2014)

Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia
por: Ruzicka, Michael, et al.
Publicado: (2022)

Transplantationsmedizin in der Intensivmedizin
por: Michels, G., et al.
Publicado: (2016)

Severe Candida glabrata pancolitis and fatal Aspergillus fumigatus pulmonary infection in the setting of bone marrow aplasia after CD19-directed CAR T-cell therapy – a case report
por: Rejeski, Kai, et al.
Publicado: (2021)

Teamspezifische Auswirkungen der Corona-Pandemie auf Mitarbeiter:innen der Internistischen Intensivmedizin eines Krankenhauses der Maximalversorgung
por: Wolff, Jochen, et al.
Publicado: (2022)

The PI3K∂-Selective Inhibitor Idelalisib Induces T- and NK-Cell Dysfunction Independently of B-Cell Malignancy-Associated Immunosuppression
por: Rohrbacher, Lisa, et al.
Publicado: (2021)

Aspergillus tracheobronchitis in COVID-19 patients with acute respiratory distress syndrome: a cohort study
por: Koehler, Philipp, et al.
Publicado: (2022)

Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma
por: Lechner, Axel, et al.
Publicado: (2017)

Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 chimeric antigen receptor T-cell therapy in advanced B-cell malignancies
por: Cordas dos Santos, David M., et al.
Publicado: (2022)

Der knochenmarktransplantierte Patient auf der Intensivstation
por: Stecher, S.-S., et al.
Publicado: (2021)

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
por: Banck, Jan Christoph, et al.
Publicado: (2021)

COVID‐19 associated pulmonary aspergillosis
por: Koehler, Philipp, et al.
Publicado: (2020)

Consensus statement for cancer patients requiring intensive care support
por: Kiehl, M. G., et al.
Publicado: (2018)

PTCY-Based Haploidentical Donor Transplantation versus HLA-Matched Related and Unrelated Donor Transplantations in Patients with Refractory or Relapsed Lymphoma—A Matched-Pair Analysis
por: Haebe, Sarah, et al.
Publicado: (2023)

Characterization of tumor-associated B-cell subsets in patients with colorectal cancer
por: Shimabukuro-Vornhagen, Alexander, et al.
Publicado: (2014)

TIGIT(+) NK cells in combination with specific gut microbiota features predict response to checkpoint inhibitor therapy in melanoma patients
por: Tsakmaklis, Anastasia, et al.
Publicado: (2023)

Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis
por: Garcia Borrega, Jorge, et al.
Publicado: (2022)

Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma
por: Lechner, Axel, et al.
Publicado: (2019)

Clinical Course and Outcome of Patients with SARS-CoV-2 Alpha Variant Infection Compared to Patients with SARS-CoV-2 Wild-Type Infection Admitted to the ICU
por: Garcia Borrega, Jorge, et al.
Publicado: (2021)

Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma
por: Leuchte, Katharina, et al.
Publicado: (2020)

Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO)
por: Kochanek, Matthias, et al.
Publicado: (2019)

PET/CT imaging for tumour response assessment to immunotherapy: current status and future directions
por: Unterrainer, Marcus, et al.
Publicado: (2020)

Advances in cancer immunotherapy 2019 – latest trends
por: Kruger, Stephan, et al.
Publicado: (2019)

Toxicities and Response Rates of Secondary CNS Lymphoma After Adoptive Immunotherapy With CD19-Directed Chimeric Antigen Receptor T Cells
por: Karschnia, Philipp, et al.
Publicado: (2022)

Krebspatienten in der operativen Intensivmedizin
por: Annecke, Thorsten, et al.
Publicado: (2018)

Robotic Stereotactic Radiosurgery in Melanoma Patients with Brain Metastases under Simultaneous Anti-PD-1 Treatment
por: Trommer-Nestler, Maike, et al.
Publicado: (2018)

Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016
por: Lehmann, Clara, et al.
Publicado: (2017)

Addition of Radiotherapy to Immunotherapy: Effects on Outcome of Different Subgroups Using a Propensity Score Matching
por: Trommer, Maike, et al.
Publicado: (2020)

Severe hypertension and (renal) thrombotic microangiopathy: solving the puzzle
por: Wehrmann, Florian, et al.
Publicado: (2023)

Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment
por: Schoeberl, Florian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vu2r1k0v43b79f9gdhv2cisr56